Overall, secondary metabolites of mulberry leaves target the PD-L1/PD-1 signaling, enhance T cell-mediated immunity, and inhibit lung cancer tumorigenesis, potentially improving the efficacy of immune checkpoint inhibitors in lung cancer treatment [172]. Here, CD274 is linked to lung cancer.